Citadel Advisors
BCAB

Citadel Advisors’s BIOATLA INC BCAB Stock Holding History

Citadel Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,714
Closed -$70.1K – 13694
2026
Q1 		$70.1K Buy
+8,714
New +$102K ﹤0.01% 12251
2025
Q4 		– Sell
-5,481
Closed -$215K – 12667
2025
Q3 		$189K Buy
+5,481
New +$127K ﹤0.01% 11314
2025
Q1 		– Sell
-1,545
Closed -$33K – 14466
2024
Q4 		$45.7K Buy
1,545
+1,541
+38,525% +$129K ﹤0.01% 12481
2024
Q3 		$380 Sell
4
-3,702
-100% -$310K ﹤0.01% 14030
2024
Q2 		$254K Buy
3,706
+2,253
+155% +$268K ﹤0.01% 9460
2024
Q1 		$250K Sell
1,453
-10
-0.7% -$1.24K ﹤0.01% 9865
2023
Q4 		$180K Sell
1,463
-830
-36% -$72K ﹤0.01% 10101
2023
Q3 		$195K Sell
2,293
-355
-13% -$45.2K ﹤0.01% 9963
2023
Q2 		$397K Sell
2,648
-7,605
-74% -$1.31M ﹤0.01% 8424
2023
Q1 		$1.37M Buy
10,253
+8,922
+670% +$1.61M ﹤0.01% 6096
2022
Q4 		$549K Sell
1,331
-279
-17% -$116K ﹤0.01% 8044
2022
Q3 		$620K Sell
1,610
-1,968
-55% -$644K ﹤0.01% 7992
2022
Q2 		$510K Buy
3,578
+1,558
+77% +$248K ﹤0.01% 8591
2022
Q1 		$505K Buy
2,020
+1,172
+138% +$490K ﹤0.01% 9367
2021
Q4 		$832K Buy
+848
New +$1.08M ﹤0.01% 8391
2021
Q3 		– Sell
-3,060
Closed -$6.48M – 13794
2021
Q2 		$6.48M Buy
3,060
+1,382
+82% +$3.12M ﹤0.01% 3899
2021
Q1 		$4.27M Sell
1,678
-2,028
-55% -$5.2M ﹤0.01% 4625
2020
Q4 		$6.3M Buy
+3,706
New +$6.19M ﹤0.01% 3292

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors's BCAB Position: Q2 2026 in Review

Citadel Advisors sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 8,714 shares — an estimated $70.1K sold.

Citadel Advisors first reported a position in BCAB in Q4 2020 and held it in 18 quarters. The position peaked at $6.48M in Q2 2021. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Citadel Advisors reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 8,714 BIOATLA INC shares in Q2 2026, an estimated $70.1K.
  • Citadel Advisors first reported a position in BIOATLA INC in Q4 2020 and held it in 18 quarters.
  • Citadel Advisors's BIOATLA INC position peaked at $6.48M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.